Research & Development



  沒有這種默片一樣的舞蹈打擾,雲瑯就把注意力放在 里啪啦作響的火堆上,酒喝完了,就抱著膝蓋來回搖晃,等待曹襄作出應答。 第一五六章 大雨瓢潑gav成网免费播放观看   “無妨,這點擔當雲氏還有!”久久视频这里只精品99热   昨夜負責近衛的軍卒被貶斥成了軍奴,這是霍去病挨了皇帝七八腳之後的成果。   “陛下,雲瑯就在您的車駕後邊……”亚洲香蕉视频在线播放   “這回我真的不知道了,敢這麼做的人我都想不出會是誰!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo